146 related articles for article (PubMed ID: 2087069)
1. [Intestinal apolipoprotein metabolism].
Steinmetz A
Klin Wochenschr; 1990; 68 Suppl 22():12-8. PubMed ID: 2087069
[TBL] [Abstract][Full Text] [Related]
2. [Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].
Couderc R; Bailleul S
Ann Biol Clin (Paris); 1998; 56(6):651-9. PubMed ID: 9853024
[TBL] [Abstract][Full Text] [Related]
3. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
5. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein E mobility between plasma lipoproteins in intravenous administration of fat emulsions (MCT, LCT)].
Steinmetz A; Schwarz S; Richter G
Infusionsther Transfusionsmed; 1992 Feb; 19(1):32-6. PubMed ID: 1600396
[TBL] [Abstract][Full Text] [Related]
7. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
Xu CF; Angelico F; Del Ben M; Humphries S
Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
[TBL] [Abstract][Full Text] [Related]
8. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein receptors.
Lestavel S; Fruchart JC
Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):461-81. PubMed ID: 8061563
[TBL] [Abstract][Full Text] [Related]
11. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
[TBL] [Abstract][Full Text] [Related]
12. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
Mahley RW; Hui DY; Innerarity TL; Beisiegel U
Arteriosclerosis; 1989; 9(1 Suppl):I14-8. PubMed ID: 2536272
[TBL] [Abstract][Full Text] [Related]
13. Receptor interactions controlling lipoprotein metabolism.
Weisgraber KH; Innerarity TL; Rall SC; Mahley RW
Can J Biochem Cell Biol; 1985 Aug; 63(8):898-905. PubMed ID: 2998579
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
[TBL] [Abstract][Full Text] [Related]
15. Anderson's disease: exclusion of apolipoprotein and intracellular lipid transport genes.
Dannoura AH; Berriot-Varoqueaux N; Amati P; Abadie V; Verthier N; Schmitz J; Wetterau JR; Samson-Bouma ME; Aggerbeck LP
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2494-508. PubMed ID: 10521380
[TBL] [Abstract][Full Text] [Related]
16. [The role of apolipoproteins in lipid metabolism].
Karádi I; Kostner GM
Ther Umsch; 1990 Jun; 47(6):467-74. PubMed ID: 2165281
[TBL] [Abstract][Full Text] [Related]
17. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?
Lo CM; Nordskog BK; Nauli AM; Zheng S; Vonlehmden SB; Yang Q; Lee D; Swift LL; Davidson NO; Tso P
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G344-52. PubMed ID: 18006607
[TBL] [Abstract][Full Text] [Related]
18. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
19. [Metabolism of chylomicrons and very low density lipoproteins].
Windler E
Klin Wochenschr; 1990; 68 Suppl 22():19-22. PubMed ID: 2087074
[TBL] [Abstract][Full Text] [Related]
20. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
Chait A
Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
